Even in Denmark — Novo Nordisk's house current market — an application for Wegovy to acquire public wellbeing insurance policy coverage was rejected about the grounds that its cost was incommensurate with its therapeutic benefit.Meantime, provide constraints could dampen initial distribution inside of a current market forecast to get truly wort